Electrophysiology. Permanent pacing: New indications

Heart

Volumn 86, Issue 3, 2001, Pages 355-360

  Gold, M R ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONGESTIVE HEART FAILURE; HEART ATRIUM PACING; HEART PACING; HEMODYNAMICS; HYPERTROPHIC CARDIOMYOPATHY; PRIORITY JOURNAL; SICK SINUS SYNDROME; SYNCOPE; HEART DISEASE; HUMAN; METHODOLOGY; REVIEW;

CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; HEART DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; SICK SINUS SYNDROME; SYNCOPE;

EID: 0034877718     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Dual chamber versus ventricular pacing. Critical appraisal of current data
2. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome
3. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing
4. Comparison of the effects of physiologic pacing versus ventricular pacing on cardiovascular death and stroke
5. Relative importance of activation sequence compared to atrioventricular synchrony in left ventricular function
6. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation
7. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing
8. Randomized controlled study investigating the effect of biatrial pacing in prevention of atrial fibrillation after coronary artery bypass grafting
9. Ventricular tachycardia is not the predominant cause of monitored sudden death in heart failure
10. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: A randomized study
11. VDD pacing at short atrioventricular intervals does not improve cardiac output in patients with dilated heart failure
12. Results of atrioventricular synchronous pacing with severe congestive heart failure
13. Acute hemodynamic effects of right ventricular pacing site and pacing mode in patients with congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy
14. Optimal right ventricular pacing site in chronically implanted patients: A prospective randomized cross-over comparison of apical and outflow tract pacing
15. Acute hemodynamic effects of atrio-biventricular pacing in humans
16. Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function
17. Multisite pacing for end-stage heart failure: Early experience
18. Evaluation of different ventricular pacing sites in patients with severe heart failure: Results of an acute hemodynamic study
19. Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillation
20. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay
21. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block
22. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy
23. Dual-chamber pacing for hypertrophic cardiomyopathy; a randomized, double-blind, crossover trial
24. Pacing in hypertrophic obstructive cardiomyopathy (PIC). A randomised crossover study
25. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized, double-blind, crossover study (M-PATHY)
26. Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy
27. Comparisons of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole
28. A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope
29. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: A multicentre randomized study